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The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
• 
Fever: Blessing or Curse?
To the Editor: Although I agree with Dr. Mackowiak (1) that it is useful to view biological processes such as fever from an evolutionary perspective, his hypothesis is based on a misunderstanding of the process of evolution by natural selection. His assumption that the essence of evolution is "preservation of the species rather than the survival of the individual" has no basis in evolutionary theory.
Genes are "selfish" (2) . Their sole "purpose" is to make copies of themselves. If a gene's phenotype confers a survival advantage that allows an individual to reproduce, then more copies of the gene are produced. Genetically determined altruistic behavior is seen only when it benefits related individuals who are likely to carry the same gene. Thus, a gene may reduce an individual's survival if it sufficiently increases the survival of other individuals carrying the same gene. Such sacrifices are not made for "the species." If the first genes for fever decreased infection-related mortality, they would have been perpetuated through natural selection. If, however, they increased infection-related mortality for the individual but reduced contagion and subsequent mortality for unrelated individuals, these genes would not receive the benefit of natural selection.
It is not necessary for a biological system such as fever to be adaptive in all situations for it to be evolutionary advantageous. For example, when the genes for the renin-angiotensin system first appeared, they were presumably selected because of their adaptive responses to extracellular volume depletion (for example, from infectious diarrhea or acute traumatic blood loss) in individuals who could still reproduce. Fluid retention is, of course, maladaptive in cardiac dysfunction when it results in pulmonary congestion and hypoxemia. Few individuals experience congestive heart failure before or during their reproductive years, so no evolutionary survival disadvantage results from the maladaptation. Thus, biological processes such as fever or the renin-angiotensin system can be adaptive in certain circumstances and maladaptive in others and remain evolutionary advantageous. To the Editor: In his article (1), Dr. Mackowiak tries to explain why a human would evolve to develop a sometimes beneficial, other times harmful trait such as fever. He argues that one way to approach the concept is to understand evolution at the species level rather than at the individual level. Thus, a person prematurely killed by a high fever may not benefit from the fever, but other members of the species, who will no longer be exposed to the illness, will benefit (a sort of evolutionary altruism).
Eric Schwam, MD
The problem with this explanation is that most evolutionists, including Darwin, have argued that in almost all cases, evolution occurs at the level of the individual. As Stephen Jay Gould (2) points out:
Most evolutionists would now admit that group selection can occur in certain special situations (species made of very many discrete, socially cohesive groups in direct competition with each other). But they regard such situations as uncommon if only because discrete groups are often kin groups, leading to a preference for kin selection as an explanation for altruism within the group.
In other words, suppose I die of a fever in a way that allows my siblings to live. My death will have promoted the ongoing life of individuals who share many of my genes. In that respect, whatever genetic trait caused me to die altruistically will (to the extent that my siblings share the trait) be passed on to future generations, as will many of my genes. This altruism, then, is not evidence of evolution at the species level but at the individual level. My death has served to pass on some amount of my genetic information. Suppose, instead, that my act of altruism saves the lives of persons unrelated to me. What will then happen to my genes? Because I have died, I no longer have a chance to pass on my genes. And because people unrelated to me are unlikely to share this gene, the gene that caused my altruism will not be propogated. Instead, others who do not have the gene will survive, and their genes will be propogated. Evolution is generally not altruistic.
Perhaps a simpler explanation could be applied to the evolution of fever. Fever sometimes hurts, but more often it helps. Thus, one is more likely to survive (and pass on one's genes) if one can mount a fever than if one cannot. Evolution is not a perfect process. Sickle cell disease exists because it more often helps persons in areas where malaria is common than it hurts them. Why should fever be any different? overwhelming sepsis can be understood "if one accepts preservation of the species rather than survival of the individual as the essence of evolution." Preservation of the species is not the essence of evolution, and neither is survival of the individual. In a sense, the unit of evolution is the individual gene. This approach was used by W. D. Hamilton (2, 3) to explain the seemingly paradoxical evolution of altruism and is now an accepted aspect of modern evolutionary theory.
Hamilton's key insight was the observation that an individual's genes can be passed on to the next generation, not only in offspring of that individual but also in offspring of that individual's siblings and cousins. It is therefore possible for a gene that tends to greatly increase the reproductive success of relatives while slightly decreasing the reproductive success of the individual to increase in frequency in successive generations and eventually to become predominant in the population.
A similar argument can be made about the response to overwhelming sepsis. This response evolved during a time when extended families presumably lived in close proximity. The rapid death of an individual with overwhelming infection could abort an epidemic that could damage the individual's children, siblings, and cousins. Accordingly, genes associated with such a febrile response would increase in frequency. This evolutionary process acts at the level of the individual gene and not on the species as a whole.
To the Editor: I read with interest Dr. Mackowiak's article (1) . In his troubling conclusion he implies that fever may have a salutary benefit for the species that overrides the needs of the individual. It is disconcerting when a physician or scientist attributes a teleologic role to either a disease or a biological response. Scientifically, it must be considered fanciful to assume that fever has an evolutionary basis in promoting survival of a "hopelessly infected and potentially contagious individual " The author proposes that fever acts as an evolutionary stimulus to promote the survival of a species at the expense of an individual. On the surface, his assumptions seem plausible and are reminiscent of hypotheses generated by the early racial hygienics movement, which presented as axiomatic the belief that disease was useful in eliminating those who were ill or not fit in order to promote the survival of an immunologically strong species (2, 3) . No such theories of the influence of disease on the social biology of humans have ever been subjected to careful analysis or testing. Although it may seem far-fetched to a modern audience, unsupported theories of the utility of fever or infection to strengthen the more "gifted" elements of the species have historically led to a scientific and medical concept of heredity with profound political and moral implications (4) .
I encourage the editors of this and other prestigious journals to consider seriously the broader implications of unsupported perspectives that may often have as their origins unsupported genetic or social principles, especially in the light of the history of such theories in the 20th century (5).
To the Editor: Dr. Mackowiak (1) proposes that the "preservation of the species rather than survival of the individual [is] the essence of evolution." This concept is logically untenable. Evolution results in the formation of new species and in the extinction of others. If species are preserved, no evolution occurs.
Richard Dawkins' book The Selfish Gene (2) is a cogent polemic against "the erroneous assumption that the important thing in evolution is the good of the species (or the group) rather than the good of the individual (or the gene)."
Dr. Mackowiak advances the hypothesis that "the febrile response and its mediators might have evolved both as a mechanism for accelerating the recovery of infected individuals with ... mild to moderately severe systemic infections and for hastening the demise of hopelessly infected individuals, who pose a threat of epidemic disease to the species." However, he then undermines his hypothesis by identifying fever as adaptive in such contagious epidemic (or endemic) diseases as poliovirus, Coxsackie B virus, rabies, and herpesvirus but as maladaptive in gram-negative bacteremia, which is never epidemic.
If fever is adaptive for most individuals, then individual selection will maintain this trait in the population, and no need exists to invoke group selection as an explanation for the persistence of this trait. If fever is maladaptive for most individuals, can group selection explain the widespread phenomenon of febrile response to infection? This is unlikely, given that group selection is an extraordinarily rare evolutionary phenomenon that occurs in special circumstances that do not seem present here (3) .
It would be more fruitful to view the maladaptive aspects of fever in the host as side effects of the pathogen's struggle to maximize its own reproductive fitness. Some symptoms of disease (for example, diarrhea in cholera and phlegm production in respiratory infection) are clearly maladaptive for the host but favor the pathogen's transmission to other hosts, thereby enhancing the pathogen's reproductive fitness (4).
Richard B. Johnson, MD, MPH Udhailigah 31311 Saudi Arabia
To the Editor: Dr. Mackowiak (1) presents the interesting hypothesis that "if one accepts preservation of the species, rather than survival of the individual, as the essence of evolution, fever and its mediators might have evolved ... for hastening the elimination of fulminantly infected individuals who pose a threat of epidemic disease to the species."
This hypothesis uses the "species benefit fallacy" (2). As evolutionary biologists have shown (3), natural selection can only act on the individual (or on groups of closely related kin), not on the species. Any individual who died to preserve the species would fail to leave his or her traits to subsequent generations. Individuals without the trait that led to early death would leave more offspring, and the trait would tend to disappear from the population. The "essence of evolution" rests in the fact that individuals leave different numbers of surviving offspring according to their individual evolutionary fitness. The current consensus is that a trait will not evolve to preserve the species (4).
To the Editor:
In his fascinating article, Mackowiak (1) proposes an attractive hypothesis for the continuing debate on the teleologic question of fever as a friend or an enemy. This hypothesis reconciles the results of experimental and clinical studies that show fever both as friend and foe. However, it is important to note that in some of the studies attributing organic damage to fever, the damage is actually caused by hyperthermia, a wellknown mechanism of injury (2). In hyperthermia, no defenses against aggression are activated, liberation of cytokines is not implicated, and prostaglandin synthesis is not involved. Instead, a dysfunction of thermoregulatory mechanisms leads to a temperature sometimes sufficient to cause thermal damage. Although fever is a manifestation of a functional thermoregulatory system, hyperthermia is characteristic of a disarranged one. Examples of hyperthermia are heat stroke, anhydrosis, occlusive clothes, hypothalamic injuries, and malignant hyperthermia. A difference also exists experimentally between induced hyperthermia and induced fever; the former is achieved by warming and the latter by pyrogen injection.
Although I agree with Dr. Mackowiak's unifying hypothesis, some of the apparent contradictions concerning the organic effects of fever can be caused by a lack of distinction between fever and hyperthermia. It is clear that the latter must be suppressed, whereas febrile response can contribute to face aggression.
Alberto Lifshitz, MD University of Mexico Mexico City 06725 Mexico
In response: I am grateful to each of the authors for their interest in my article and for their thought-provoking reflections on theories of evolution. Of the questions they raise in their letters, the most perplexing concerns the basic unit of evolution.
Dr. Schwam maintains that the basic unit of evolution is the gene. Genes certainly play a fundamental role in the process; however, the proposition that "genes making copies of themselves" is the essence of evolution, although provocative in its simplicity, does nothing to enhance our understanding of why some genetic traits survive and others disappear during evolution. It also does not explain why fever, a biological process controlled by many genes, protects the host in certain situations and harms it in others. Similarly, if survival of the individual is the essence of evolution, why would a physiologic response (fever), maintained for more than 400 million years of the evolutionary process, accelerate the demise of individuals with sepsis? Perhaps, as Dr. Ubel suggests, the occasional pernicious effects of fever simply reflect the fact that evolution is an imperfect process. I cannot disprove this hypothesis but find it intellectually unsatisfying.
I am nevertheless grateful to Dr. Ubel for his discussion of group selection and to Dr. Fischer for sharing "Hamilton's key insight ... that an individual's genes can be passed on to the next generation, not only in the offspring of that individual but also in that individual's siblings and cousins." I believe that such group selection is precisely the means by which the febrile response might have established itself within the gene pool of primitive life forms.
Phylogenetic data suggest that the febrile response first emerged in the common ancestor of annelids and arthropods. Thus, the evolutionary struggle that ultimately established fever
understanding of evolution, the trait itself would probably have been preserved from one generation of the organism to the next.
I believe that the detrimental effects of fever during sepsis could only have been advantageous-and therefore likely to have been preserved during evolution-if the welfare of the group rather than of the individual were the primary determinant in the evolutionary process. If so, hastening the death of an individual with sepsis during an epidemic might have been a means by which a subpopulation of the early life form limited the spread of epidemic diseases among its members. If it was effective in this regard and if the epidemic disease was particularly virulent, the capacity of fever for accelerating the elimination of individuals with sepsis might have enabled a closely related subpopulation (that is, siblings and cousins) possessing the trait to survive the epidemic, whereas other unrelated subpopulations not possessing the trait died.
I agree with Dr. Schiller that his proposal is "far-fetched." I do not believe, nor am I proposing, that the primary function of the febrile response is to weed crippled persons from the species. Its primary function is to accelerate recovery from infection. Nevertheless, considerable experimental evidence indicates that the febrile response increases mortality in patients with gram-negative sepsis, a condition that, contrary to Dr. Johnson's contention, can be highly contagious and extremely lethal if the gramnegative bacillus happens to be a bacterium such as Pasteurella pestis. Fortunately, such epidemic infections are rare in humans, although they had a devastating influence earlier in our history. If similar epidemics plagued the primitive precursor of annelids and anthropods, the darker side of fever might have evolved and established itself widely within the gene pool as a result of the process of group selection so succinctly described by Dr. Ubel.
Philip A. Mackowiak, MD Department of Veterans Affairs Medical Center Baltimore, MD 21201
Noninvasive Ventilation
To the Editor: We read with interest Meyer and Hill's excellent review on noninvasive positive pressure ventilation (1) . The authors provide some selection guidelines for its use that are based on reports in the literature. According to those guidelines, noninvasive positive pressure ventilation should be avoided in patients with acute respiratory failure associated with hemodynamic instability.
We have noted that not all the cited reports included information on the hemodynamic status among their selection criteria in patients with acute disease. Further, when excluding hemodynamically unstable patients, the authors failed to define hemodynamic stability.
It is well known that conventional mechanical ventilation by endotracheal intubation may seriously alter hemodynamic status (particularly when external positive end-expiratory pressure, invasive positive pressure ventilation, or intermittent mechanical ventilation is used) (2). Hemodynamic status is less affected in patients treated with pressure support ventilation (3). We know of no reports of similar adverse effects of noninvasive positive pressure ventilation when nasal or facial masks are used. Therefore, could this type of ventilation represent a possible alternative ventilatory treatment in patients with hemodynamic instability?
We used bilevel positive airway pressure ventilation (BiPAP; Respironics, Inc.) through a nasal mask to ventilate 57 consecutive, unselected patients with acute respiratory failure who were unresponsive to oxygen and medical therapy alone. We applied noninvasive positive pressure ventilation for almost 22 hours daily, with a median inspiratory positive airway pressure of 15 cm H 2 0 (maximum, 20 cm H 2 6; minimum, 8 cm H 2 0) and a median expiratory positive airway pressure of 4 cm H 2 0 (range, 8 cm H 2 0 to 3 cm H 2 0). Seven patients had hypotension (systolic blood pressure <100 mm Hg; mean, 88 ± 6 mm Hg), 11 had radiologic and clinical findings of pulmonary edema, 20 had edema of the legs; 38 had tachycardia; 21 had hypertension; and 20 had arrhythmias. After 24 hours of BiPAP ventilation, only three patients with initial normal blood pressure and none of those with hypotension showed a decrease of 15 mm Hg or more in their mean blood pressure. None failed to respond to BiPAP. Of the 57 patients, 39 were successfully ventilated with BiPAP, and 18 patients required intubation or died. At the time of hospitalization, we found no significant variations in blood pressure, heart rate, presence of edema of the legs, arrhythmias, respiratory rate, or blood gas values between patients successfully ventilated with BiPAP and those who failed to respond to treatment. Only the prognostic score of the Acute Physiology and Chronic Health Evaluation III (APACHE III) was significantly higher in patients who failed to respond to noninvasive positive pressure ventilation (P < 0.01). Even in our previous report of 30 patients with severe exacerbations of chronic obstructive pulmonary disease, we found the APACHE III score to be the only determinant of success or failure of bilevel noninvasive positive pressure ventilation (4) .
Clearly, our experience does not have the power of a perfectly designed study. It could, however, be of interest because it presents a series of unselected patients, including those who were hemodynamically unstable. Hemodynamic instability is often associated with exacerbation of obstructive airway disease and other causes of respiratory distress in patients with auto-positive end-expiratory pressure, even in the absence of pulmonary edema (5) . Clinical experience suggests that in acutely ill patients, there is often not enough time to evaluate the stability of the hemodynamic status before a decision to ventilate must be made. We therefore believe that when intensive care is available and promptly administered, noninvasive positive pressure ventilation may be attempted as a first-step treatment, even in hemodynamically unstable patients. In response: Confalonieri and colleagues raise the issue of appropriate selection guidelines for the use of noninvasive positive pressure ventilation in patients with acute respiratory failure. They correctly point out that "hemodynamic instability" was not precisely defined in our review, and they report their experience with a series of patients, including some with hypotension, most of whom were successfully treated with noninvasive positive pressure ventilation. Information on the appropriate use of noninvasive positive pressure ventilation in patients with acute respiratory failure is evolving, and it is not possible to delineate precise patient selection criteria because of the lack of well-designed scientific studies in the literature. The selection guidelines that we presented in our article were culled from currently available studies and our own experience, but it is important to emphasize that they are only guidelines and that clinical judgment must always be exercised when they are applied in individual patients.
Confalonieri and colleagues also failed to precisely define hemodynamic instability, and their definition of hypotension (systolic blood pressure <100 mm Hg) is fairly lenient. We agree that the patients described by Confalonieri and associates appear to have been appropriately selected as candidates for noninvasive positive pressure ventilation, and the success rate of approximately 66% compares favorably with those of other similar series. We maintain, however, that some patients with "hemodynamic instability" remain poor candidates for this treatment. These include patients with not only hypotension but also with evidence of inadequate organ perfusion not easily reversed by fluid resuscitation or pressor agents. In such patients, intubation and paralysis may be necessary to minimize the energy consumption by respiratory muscles, and application of noninvasive positive pressure ventilation could be deleterious by delaying the use of more definitive therapeutic measures. 
Nicholas S. Hill, MD
Steven L. Oscherwitz, MD Tempe, AZ 85282
In response: We initially considered the possibility of a bacterial infection with Vibrio. Multiple blood cultures and a skin culture were negative. In addition, this patient's presentation was not consistent with V vulnificus infection, which has been associated with three very different clinical syndromes: primary septicemia, wound infections, and gastrointestinal illness without septicemia or wound infection (1). Patients with primary septicemia have a preexisting liver disease, and some have reported a recent history of consuming raw oysters. Patients with wound infections often have fever, pain and swelling at the wound site, and cellulitis. In a study of the clinical and epidemiologic features of V. vulnificus infections in Florida from 1981 to 1987, V vulnificus was cultured from the wound site alone in 8 of 17 patients with wound infections and from skin lesions or blood in the rest. Of the four patients who died, all had blood cultures positive for V. vulnificus, and all had underlying chronic diseases. None of the 11 patients without chronic diseases died. Rapid extension of the cellulitis and swelling in the same extremity as the wound was seen.
Our patient was a healthy young man with no underlying illness. Dexamethasone was started in his second visit to the hospital. At that time, 24 hours after the sting, he was already encephalopathic. Blood and wound cultures were all negative, and no evidence of cellulitis or inflammation was noted surrounding the lesion. Liver study findings did not suggest ischemic liver injury.
A lower IgG titer is more consistent with previous exposure. Although it would have been preferable to measure IgM, the technique for this is not available. Because the titers were high and were from the same species recognized as the offender, we feel that the serologic results indicate acute envenomation. 
Methamphetamine-induced Choreoathetosis and Rhabdomyolysis
To the Editor: Illicit use of a crystalized, smokable form of methamphetamine ("ice") has markedly increased (1). Small doses can produce significant central nervous system, cardiovascular, and systemic toxic effects. We describe a previously healthy man who developed choreoathetosis and rhabdomyolysis after using crystalized methamphetamine.
A 50-year-old man presented to an inner-city hospital in metropolitan Atlanta reporting a 2-day history of hiccups and uncontrollable writhing movements of his face and hands. He had not previously experienced any similar symptoms. He denied any family history of movement disorders, ethanol or substance abuse, intake of medications, or previous illnesses. He was employed as an insect exterminator and had not recently changed any of the chemicals with which he worked. In fact, he had been on vacation from his job for the previous week.
Physical examination showed a hypomanic affect and noticeable choreiform movements of the upper extremities, head, and neck. His temperature was 38 °C, and orthostatic changes were evident. Dry mucous membranes and flat neck veins were noted. He was alert and oriented but also hyperverbal, with loose associations, tangential thoughts, and a decreased attention span. Laboratory values included a sodium level of 119 mEq/L, a potassium level of 2.9 mEq/L, a chlorine level of 62 mEq/L, a bicarbonate level of 34 mEq/L, a blood urea nitrogen level of 63 mg/dL, a creatinine level of 6.0 mg/dL, a phosphorus level of 6.3 mmol/L, a serum glutamic-oxaloacetic transaminase level of 177 IU/L, and a uric acid level of 9.7 mg/dL. Examination of roomair blood gases showed a P0 2 of 65 mm Hg, a PC0 2 of 40 mm Hg, and a pH of 7.61. Urinalysis showed a pH of 8.0 and blood positivity by dipstick, but no erythrocytes were seen on microscopic evaluation. His electrocardiogram was remarkable only for a prolonged QT interval. Additional laboratory studies were significant for a creatine kinase level of 7664 IU/L, which peaked at 19 790 IU/L, and a lactate dehydrogenase level of 491 IU/L. Serum lithium level; ceruloplasmin, ammonia, and thyroid function test results; rheumatoid factor; antinuclear antibodies; and antistreptolysin-O titers were all negative or within normal limits. Extensive drug toxicology screens were positive only for amphetamines.
Treatment included vigorous hydration with normal saline. During a 7-day hospitalization, the choreiform movements, electrolyte abnormalities, and creatine kinase levels gradually returned to normal. On hospital day 6, the patient's girlfriend brought in a packet containing a white crystalline substance, which the patient refused to specifically identify. He admitted, however, that he believed the substance caused his condition. The substance was analyzed in the toxicology laboratory and was determined to be methamphetamine.
Rhee and colleagues (2) reported three cases of acute choreoathetosis associated with amphetamine-like drugs. In addition, a few cases of rhabdomyolysis related to methamphetamine have been documented (3) . A single case of choreoathetosis and rhabdomyolysis related to pemoline, a sympathomimetic agent similar to amphetamine and ritalin, was reported in 1988 (4).
In our patient, the choreoathetosis was probably related to the central dopaminergic effects of methamphetamine (5), as was the patient's mildly psychotic and agitated behavior. Rhabdomyolysis was most likely a result of the drug itself, possibly in combination with the excessive, uncontrollable muscular activity of chorea. The severe metabolic derangements were probably the result of significant dehydration following an "amphetamine run," rhabdomyolysis, and the alkaline property of amphetamines.
Laurence S. Sperling, MD
Emory University School of Medicine Atlanta, GA 30322
Blueberry Muffins and Mystery Novels
To the Editor: I am saddened and embarrassed to have read Dr. Linzer's essay "Blueberry Muffins and Mystery Novels" (1) . The type of experience described and the relationship established with the patient is something that those of us who practice medicine 12 months of every year share on a daily basis. Relating to our patients in a personal manner without "detached concern that is supposed to define our relationships with patients" is something that we should do most of the time. It should not be something so unusual as to be considered "crossing over the line."
How unfortunate for the medical student who told Dr. Linzer that "this was one of the most powerful experiences he had had in medical school," when it should be a fairly common one. For many thousands of physicians it is, was, and always will be part of being a doctor. In response: If only we all had the opportunity to establish long-lasting and meaningful relationships with patients on a daily basis! Certainly, few patients today would say that their physicians connect with them, explain things clearly, and take the time to get to know them. As Co-Chair of the Society of General Internal Medicine's Task Force on Career Choice, I have spent years asking medical students why they are no longer interested in careers in internal medicine (1, 2) . The reason given most often is an inability to establish meaningful relationships with patients during medical training. The students ask us to increase outpatient exposure to correct this problem.
William Burns, MD
Thus, Dr. Burns' perception may depend on location. The outpatient-based physician will usually connect with his or her patients over the years. However, I remember when I was a medical house officer and would work all night to restore a desperately ill patient to health. In the morning, the private physician would walk in and the patient would glow at his doctor and say how happy he was to see him. I would feel left out of that "connexional" (3) energy.
The in-hospital training environment is toxic to good relationships. Patients enter desperately ill and leave after a diagnostic-related group-determined, foreshortened length of stay, long before a house officer, student, or attending physician can establish a relationship with them. Being the "attending of the month" on the wards (as I was with Mrs. Tyler) leaves one particularly vulnerable to this situation. To recapture students' (and perhaps our own) interest in internal medicine, we will need to either alter this environment or put students in physicians' offices, where they can see patients in a longitudinal manner and establish the relationships craved by those of us who chose internal medicine (4) . I agree that it was "unfortunate" for my student that this should have been one of his most "powerful experiences during medical school." But it was, and we must not let that remain the case. Courses such as the one run by Dr. Mack Lipkin at New York University (eloquently described in Anna Quindlen's recent New York Times article [5] ) will help many of us learn how to restore medicine to the personally connected profession described by Dr. Burns. Because many physicians fear that health reform, with its emphasis on managed care and "business-like medicine," will further endanger the doctor-patient relationship, we must insist that this relationship be the core of medical practice and that sufficient time in the office and at the bedside must be allowed for it to flourish. Thanks to Reviewers-1994 
